Monthly Archives: November 2014

Targeted Medical Pharma, Inc. Announces Q3 Financial Results and Clinical Program Updates

Los Angeles, CA, November 18, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) a drug discovery and development biotechnology company, today announced financial results for its third quarter ended September 30, 2014 and clinical trial updates. The company reported significant improvement in both net loss and net loss before interest, taxes, depreciation and amortization, and stock based compensation (Adjusted EBITDA*) on a quarter-over-quarter basis. In Addition, in Q3, the company reported major advances in the development of new treatments for both chronic low back pain Continue reading →